Your session is about to expire
← Back to Search
Bilateral TMS for Autism Spectrum Disorder (RESTORE Trial)
RESTORE Trial Summary
This trial will study whether theta burst stimulation can help ease depression in people with autism spectrum conditions.
- Autism Spectrum Disorder
- Autism
- Depression
RESTORE Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.RESTORE Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What is the aggregate figure for participants enrolled in this experiment?
"Affirmative. Clinicaltrials.gov registers that this medical trial, which was posted on November 24th 2021, is actively recruiting individuals. The research requires the enrollment of approximately 24 people at one healthcare facility."
Is it still possible to participate in the trial?
"According to clinicaltrials.gov, the recruitment process for this medical trial is currently ongoing - it was first posted on November 24th 2021 and updated as recently as April 1st 2022."
Are there any age restrictions when it comes to enrolling in this clinical trial?
"This trial is specifically seeking out patients aged between 12 and 26. For comparison, there are 583 trials for minors and 1491 studies for seniors."
Am I qualified to take part in this research?
"To join this autism-related clinical trial, 24 participants aged 12 to 26 must be identified. The requisite characteristics are a diagnosis on the autism spectrum, an absence of intellectual disability, and evidence of depression not assuaged through established treatments (such as SSRIs or CBT)."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger